Thrombolytic therapy in older acute ischemic stroke patients withgastrointestinal malignancy or recent bleeding

摘要

There are limited data on the safety of intravenous recombinant tissueplasminogen activator (rtPA) for treating acute ischemic stroke in patientswith gastrointestinal malignancy or recent gastrointestinal bleeding within21 days of their index stroke.